Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (27 quarters reported)
$346M in Q4 2019 → $977M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Mbx Biosciences Inc | 4.5% | Added 0.0% | 800,173 | $44.2M |
| EL Eli Lilly & Co | 4.3% | Added 1.1% | 35,000 | $42M |
| Cvs Health Corp | 4.1% | Added 1.2% | 391,791 | $40.5M |
| Dexcom Inc | 3.7% | Trimmed 22% | 534,767 | $36M |
| Ptc Therapeutics Inc | 3.6% | Added 1.0% | 435,691 | $35.5M |
| Arcus Biosciences Inc | 2.9% | Trimmed 24% | 919,266 | $28.3M |
| Structure Therapeutics Inc | 2.7% | Added 109% | 485,661 | $26.1M |
| Viridian Therapeutics Inc | 2.6% | Added 147% | 1,377,576 | $25.3M |
| Agios Pharmaceuticals Inc | 2.5% | Added 66% | 669,046 | $24.8M |
| Inhibrx Biosciences Inc | 2.5% | New | 256,950 | $24.3M |
| Xenon Pharmaceuticals Inc | 2.5% | Trimmed 20% | 397,379 | $24M |
| Edgewise Therapeutics Inc | 2.4% | Added 79% | 577,036 | $23.4M |
| Unitedhealth Group Inc | 2.4% | New | 55,921 | $23.2M |
| Stryker Corporation | 2.2% | Trimmed 56% | 67,973 | $21.4M |
| IH Iqvia Hldgs Inc | 2.1% | Added 22% | 105,811 | $20.4M |
| Zimmer Biomet Holdings Inc | 2.0% | Trimmed 14% | 232,557 | $20M |
| Insulet Corp | 2.0% | Trimmed 16% | 131,378 | $20M |
| Assembly Biosciences Inc | 2.0% | Added 75% | 721,181 | $19.8M |
| Syndax Pharmaceuticals Inc | 2.0% | Trimmed 2.7% | 877,256 | $19.2M |
| Eyepoint Inc | 1.9% | Trimmed 4.9% | 1,288,163 | $18.4M |
| Tenet Healthcare Corp | 1.9% | Added 94% | 97,280 | $18.2M |
| Livanova PLC | 1.8% | Trimmed 48% | 210,529 | $17.3M |
| Ani Pharmaceuticals Inc | 1.7% | Trimmed 28% | 202,907 | $16.8M |
| Biocryst Pharmaceuticals Inc | 1.7% | Trimmed 4.9% | 1,624,279 | $16.2M |
| Alnylam Pharmaceuticals Inc | 1.6% | Added 88% | 50,672 | $15.3M |
| Indivior Pharmaceuticals Inc | 1.5% | New | 364,269 | $14.9M |
| Envista Holdings Corporation | 1.5% | Trimmed 22% | 553,916 | $14.6M |
| Bright Minds Biosciences Inc | 1.5% | Added 411% | 205,053 | $14.4M |
| Xeris Biopharma Holdings Inc | 1.5% | Added 5.0% | 1,807,621 | $14.3M |
| Avalo Therapeutics Inc | 1.4% | New | 766,290 | $14.2M |
| 4M 4d Molecular Therapeutics In | 1.3% | Added 81% | 948,184 | $12.6M |
| Immunome Inc | 1.3% | Added 47% | 594,202 | $12.6M |
| Stoke Therapeutics Inc | 1.2% | Added 5.6% | 355,443 | $11.6M |
| Waters Corp | 1.2% | Added 14% | 30,206 | $11.3M |
| Alto Neuroscience Inc | 1.2% | New | 429,035 | $11.3M |
| Oruka Therapeutics Inc | 1.1% | New | 113,188 | $10.8M |
| AB Adaptive Biotechnologies Cor | 1.1% | Trimmed 12% | 486,984 | $10.4M |
| Absci Corporation | 1.1% | Trimmed 52% | 894,374 | $10.4M |
| Mineralys Therapeutics Inc | 1.1% | Added 0.1% | 380,354 | $10.3M |
| Cogent Biosciences Inc | 1.0% | Added 153% | 253,365 | $9.81M |
| UN Uniqure Nv | 1.0% | Added 0.6% | 208,170 | $9.59M |
| Tarsus Pharmaceuticals Inc | 1.0% | New | 150,000 | $9.44M |
| Amneal Pharmaceuticals Inc | 1.0% | Added 80% | 541,190 | $9.37M |
| Irhythm Holdings Inc | 0.8% | Added 68% | 67,267 | $8M |
| Cryoport Inc | 0.8% | New | 508,324 | $7.98M |
| Boston Scientific Corp | 0.8% | Trimmed 60% | 180,481 | $7.7M |
| Climb Bio Inc | 0.8% | New | 563,484 | $7.35M |
| Amylyx Pharmaceuticals Inc | 0.7% | Trimmed 36% | 398,782 | $7.16M |
| Upstream Bio Inc | 0.7% | Added 19% | 935,247 | $6.47M |
| Resmed Inc | 0.7% | New | 32,983 | $6.43M |
| Urogen Pharma Ltd | 0.7% | Trimmed 37% | 174,064 | $6.41M |
| Align Technology Inc | 0.6% | Added 74% | 36,963 | $6.23M |
| Carlsmed Inc | 0.6% | Added 15% | 597,318 | $6.2M |
| AH Aveanna Healthcare Hldgs Inc | 0.6% | New | 714,451 | $6.12M |
| Caredx Inc | 0.6% | Trimmed 31% | 202,417 | $5.77M |
| Si Bone Inc | 0.5% | Trimmed 12% | 328,686 | $5.36M |
| Vir Biotechnology Inc | 0.5% | Trimmed 4.9% | 475,279 | $4.84M |
| Erasca Inc | 0.5% | Trimmed 36% | 258,684 | $4.74M |
| Shoulder Innovations Inc | 0.5% | New | 226,212 | $4.59M |
| WH Waystar Hldg Corp | 0.4% | Trimmed 54% | 203,986 | $4.19M |
Showing top 60 of 77 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Kalvista Pharmaceuticals Inc | Exited | −1,835,506 | −$36.9M | — |
| Stryker Corporation | Trimmed | −86,798 | −$27.3M | 2.2% |
| Inhibrx Biosciences Inc | New | +256,950 | +$24.3M | 2.5% |
| Unitedhealth Group Inc | New | +55,921 | +$23.2M | 2.4% |
| QN Qiagen Nv | Exited | −500,000 | −$20M | — |
| Abbvie Inc | Exited | −75,000 | −$16.3M | — |
| Livanova PLC | Trimmed | −193,436 | −$15.9M | 1.8% |
| Viridian Therapeutics Inc | Added | +819,640 | +$15.1M | 2.6% |
| Indivior Pharmaceuticals Inc | New | +364,269 | +$14.9M | 1.5% |
| Avalo Therapeutics Inc | New | +766,290 | +$14.2M | 1.4% |
Showing the 10 largest of 106 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| EL Eli Lilly & Co | New | +34,616 | +$31.8M | 3.3% |
| Masimo Corp | Exited | −200,000 | −$26M | — |
| Terns Pharmaceuticals Inc | Exited | −620,877 | −$25.1M | — |
| QN Qiagen Nv | Exited | −494,351 | −$22.2M | — |
| Amicus Therapeutics Inc | Exited | −1,487,283 | −$21.2M | — |
| Mckesson Corp | Trimmed | −23,679 | −$20.5M | 1.1% |
| QN Qiagen Nv | New | +500,000 | +$20M | 2.1% |
| Xenon Pharmaceuticals Inc | Added | +342,851 | +$19.9M | 3.0% |
| KP Kiniksa Pharmaceuticals Intl | Trimmed | −406,024 | −$19.6M | 1.3% |
| Ptc Therapeutics Inc | Added | +271,185 | +$18.5M | 3.0% |
Showing the 10 largest of 116 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Exited | −80,000 | −$48M | — |
| Dexcom Inc | Added | +415,847 | +$27.6M | 3.7% |
| Masimo Corp | New | +200,000 | +$26M | 2.5% |
| Eyepoint Inc | New | +1,088,033 | +$19.9M | 1.9% |
| Biogen Inc | Trimmed | −94,740 | −$16.7M | 0.6% |
| Waters Corp | New | +41,899 | +$15.9M | 1.5% |
| Alnylam Pharmaceuticals Inc | Trimmed | −39,987 | −$15.9M | 1.8% |
| Mettler Toledo International | New | +10,988 | +$15.3M | 1.5% |
| Stryker Corporation | Added | +41,364 | +$14.5M | 3.5% |
| Agilent Technologies Inc | New | +100,000 | +$13.6M | 1.3% |
Showing the 10 largest of 110 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | New | +80,000 | +$48M | 5.0% |
| Tenet Healthcare Corp | Trimmed | −94,554 | −$19.2M | 1.6% |
| Verona Pharma PLC | Exited | −197,898 | −$18.7M | — |
| Biogen Inc | New | +130,165 | +$18.2M | 1.9% |
| EL Eli Lilly & Co | Trimmed | −23,296 | −$17.8M | 0.8% |
| Revvity Inc | Exited | −157,196 | −$15.2M | — |
| IH Iqvia Hldgs Inc | Trimmed | −79,500 | −$15.1M | 0.6% |
| Boston Scientific Corp | Added | +151,211 | +$14.8M | 4.4% |
| Gilead Sciences Inc | Exited | −131,675 | −$14.6M | — |
| CC Cooper Cos Inc | Trimmed | −208,956 | −$14.3M | 1.3% |
Showing the 10 largest of 101 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BD Becton Dickinson & Co | Exited | −120,283 | −$27.6M | — |
| Unitedhealth Group Inc | Exited | −50,213 | −$26.3M | — |
| IH Iqvia Hldgs Inc | New | +109,500 | +$17.3M | 2.0% |
| Genedx Holdings Corp | New | +175,000 | +$16.2M | 1.9% |
| Stryker Corporation | Trimmed | −27,314 | −$10.8M | 2.3% |
| Gilead Sciences Inc | Trimmed | −87,275 | −$9.68M | 1.7% |
| Danaher Corporation | Added | +46,840 | +$9.25M | 2.5% |
| Dexcom Inc | Added | +95,508 | +$8.34M | 2.3% |
| Tenet Healthcare Corp | Trimmed | −44,534 | −$7.84M | 3.4% |
| Insulet Corp | Trimmed | −24,752 | −$7.78M | 3.8% |
Showing the 10 largest of 102 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Verona Pharma PLC | Trimmed | −460,236 | −$29.2M | 2.0% |
| Zimmer Biomet Holdings Inc | New | +200,500 | +$22.7M | 2.7% |
| Cvs Health Corp | Added | +316,736 | +$21.5M | 4.0% |
| IT Intra-cellular Therapies Inc | Exited | −243,123 | −$20.3M | — |
| AL Abbott Labs | Exited | −176,994 | −$20M | — |
| Biomarin Pharmaceutical Inc | New | +277,252 | +$19.6M | 2.3% |
| Gilead Sciences Inc | Trimmed | −155,875 | −$17.5M | 2.9% |
| Unitedhealth Group Inc | Added | +30,213 | +$15.8M | 3.1% |
| Revvity Inc | New | +139,557 | +$14.8M | 1.8% |
| QN Qiagen Nv | New | +359,644 | +$14.4M | 1.7% |
Showing the 10 largest of 109 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Teleflex Incorporated | Exited | −96,144 | −$23.8M | — |
| Gilead Sciences Inc | Added | +245,800 | +$22.7M | 4.6% |
| Stryker Corporation | Added | +49,717 | +$17.9M | 3.7% |
| LP Longboard Pharmaceuticals In | Exited | −491,272 | −$16.4M | — |
| Mckesson Corp | New | +23,000 | +$13.1M | 1.7% |
| Viridian Therapeutics Inc | Added | +662,634 | +$12.7M | 2.8% |
| Agios Pharmaceuticals Inc | Exited | −285,099 | −$12.7M | — |
| Edwards Lifesciences Corp | New | +145,214 | +$10.8M | 1.4% |
| Unitedhealth Group Inc | New | +20,000 | +$10.1M | 1.3% |
| Boston Scientific Corp | Trimmed | −109,842 | −$9.81M | 4.0% |
Showing the 10 largest of 103 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Teleflex Incorporated | New | +96,144 | +$23.8M | 3.0% |
| UT United Therapeutics Corp Del | Trimmed | −47,350 | −$17M | 2.9% |
| Elevance Health Inc | Exited | −27,751 | −$15M | — |
| Keros Therapeutics Inc | Added | +223,155 | +$13M | 3.1% |
| Merck & Co Inc | Exited | −100,000 | −$12.4M | — |
| Humana Inc | Exited | −30,037 | −$11.2M | — |
| Stryker Corporation | New | +28,000 | +$10.1M | 1.3% |
| Viridian Therapeutics Inc | New | +425,000 | +$9.67M | 1.2% |
| Arcus Biosciences Inc | Added | +610,219 | +$9.33M | 2.0% |
| Tenet Healthcare Corp | Trimmed | −55,174 | −$9.17M | 2.0% |
Showing the 10 largest of 106 changes.
Loading...
